SMYD3 and diffuse large B-cell lymphoma: Patients of DLBCL with high levels of SMYD3 protein were more likely to have a higher Ann Arbor stage (III and IV; P = 0.018) and a higher level of serum LDH (>240 U/l, P = 0.032).